COMPARATIVE STUDY
JOURNAL ARTICLE
RANDOMIZED CONTROLLED TRIAL
Add like
Add dislike
Add to saved papers

CT angiography of the renal arteries: comparison of lower-tube-voltage CTA with moderate-concentration iodinated contrast material and conventional CTA.

OBJECTIVE: The objective of our study was to investigate the feasibility of an 80-kVp protocol using a moderate-concentration contrast medium (CM) for CT angiography of the renal arteries by comparison with a conventional 120-kVp protocol using a high-concentration CM.

SUBJECTS AND METHODS: Attenuation values and signal-to-noise ratios (SNRs) were determined in a phantom for the 120-kVp protocol with a high-concentration CM and the 80-kVp protocol with a moderate-concentration CM. In addition, 50 patients were prospectively enrolled in the study: 25 were scanned with 120 kVp and 200 effective mAs (mAs(eff)) after the administration of 110 mL of high-concentration CM (370 mg I/mL), and the other 25 were scanned with 80 kVp and 585 mAs(eff) after the administration of 110 mL of moderate-concentration CM (300 mg I/mL). Images of the two groups were compared in terms of arterial attenuation, SNR, contrast-to-noise ratio (CNR), and subjective degree of arterial enhancement and image quality.

RESULTS: The mean attenuation of the main renal artery was significantly higher (p < 0.001) in the 80-kVp group who received moderate-concentration CM (mean ± SD, 370.0 ± 65.0 HU) than in the 120-kVp group who received high-concentration CM (269.9 ± 27.8 HU) without significant differences in SNR and CNR values. The 80-kVp protocol had significantly higher quality scores for arterial enhancement, sharpness of the artery, and overall diagnostic quality compared with the 120-kVp protocol. The effective dose of the 80-kVp protocol (4.5 mSv) was 8.2% lower than that of the 120-kVp protocol (4.9 mSv).

CONCLUSION: The use of 80 kVp with moderate-concentration CM could improve arterial enhancement and provide superior image quality with a smaller amount of iodine and a lower radiation dose.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app